epirubicin has been researched along with Complication, Postoperative in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (25.00) | 18.2507 |
2000's | 2 (12.50) | 29.6817 |
2010's | 8 (50.00) | 24.3611 |
2020's | 2 (12.50) | 2.80 |
Authors | Studies |
---|---|
Bateman, A; Byrne, JP; Grace, BL; Iveson, T; Jackson, A; Kelly, JJ; Noble, F; Pucher, PH; Rahman, SA; Rees, C; Underwood, TJ; Walker, RC | 1 |
Gęca, K; Małecka-Massalska, T; Mlak, R; Pelc, Z; Polkowski, WP; Rawicz-Pruszyński, K; Sędłak, K; Skórzewska, M | 1 |
Braak, JPBM; Cats, A; Claassen, YHM; de Steur, WO; Dikken, JL; Hartgrink, HH; Jansen, EPM; Meershoek-Klein Kranenbarg, WM; Putter, H; Trip, AK; van Berge Henegouwen, MI; van de Velde, CJH; van Grieken, NCT; van Sandick, JW; Verheij, M | 1 |
Bu, JH; Bu, QA; Cui, T; You, FP; Yuan, QZ | 1 |
Blohmer, JU; Eggemann, H; Eidtmann, H; Fasching, P; Gerber, B; Hanusch, C; Hauschild, M; Huober, J; Jackisch, C; Kittel, K; Kunz, G; Loibl, S; Nekljudova, V; Rezai, M; Schrader, I; Solbach, C; Tesch, H; Untch, M; von Minckwitz, G | 1 |
Baba, H; Beppu, T; Fujiyama, S; Haraoka, K; Komori, H; Okabe, K; Ouchida, Y; Sano, O; Yamanaka, T | 1 |
Blank, S; Bruckner, T; Büchler, MW; Grenacher, L; Heger, U; Jäger, D; Kunzmann, R; Langer, R; Lordick, F; Ott, K; Schmidt, T; Sisic, L; Springfeld, C; Stange, A; Weichert, W; Wiecha, C | 1 |
Griffin, SM; Navidi, M; Sinclair, R; Sumpter, K | 1 |
De Kraker, J; Dijkgraaf, MG; Heij, H; Jagt, CT; Taminiau, JA; Ten Kate, F; Verschuur, AC; Zuckermann, M | 1 |
Hirohara, J; Ikeda, H; Kaibori, M; Kariya, S; Koreeda, C; Kwon, AH; Nakahashi, Y; Okazaki, K; Sawada, S; Seki, T; Tanigawa, N | 1 |
Auriemma, A; Bassi, C; Boz, G; Cantore, M; Frigerio, I; Giardino, A; Girelli, R; Mambrini, A; Orlandi, M; Salvia, R | 1 |
Ho, HS; Ong, HS | 1 |
Badellino, F; Canavese, G; Catturich, A; Gipponi, M; Repetto, L; Sertoli, MR; Tomei, D; Vecchio, C | 1 |
Callegaro, D; Fantoni, U; Favaretto, A; Festi, G; Loy, M; Paccagnella, A; Rea, F; Sartori, F | 1 |
Bonavina, L; Incarbone, R; Peracchia, A; Via, A | 1 |
Ali, NM; Eissa, S; Elattar, I; Elsebai, I; Gad el Mawla, N; Habboubi, N; Hamza, MR; Khaled, H; Magrath, I; Mansour, MA | 1 |
5 trial(s) available for epirubicin and Complication, Postoperative
Article | Year |
---|---|
Observation and analysis of clinical efficacy of breast-conserving therapy integrated with neoadjuvant chemotherapy on Breast Cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; China; Docetaxel; Epirubicin; Female; Humans; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Postoperative Complications; Quality of Life; Recurrence; Survival Analysis; Treatment Outcome | 2018 |
Surgical outcome after neoadjuvant chemotherapy and bevacizumab: results from the GeparQuinto study (GBG 44).
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Docetaxel; Epirubicin; Female; Follow-Up Studies; Humans; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Postoperative Complications; Prognosis; Prospective Studies; Taxoids; Young Adult | 2014 |
A prospective randomized controlled trial of preoperative whole-liver chemolipiodolization for hepatocellular carcinoma.
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheterization; Chemotherapy, Adjuvant; Disease-Free Survival; Epirubicin; Ethiodized Oil; Female; Hepatectomy; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Outcome and Process Assessment, Health Care; Postoperative Complications; Preoperative Care; Treatment Outcome | 2012 |
Surgical complications related to peri-operative adjuvant chemotherapy in breast cancer. Results of a prospective, controlled, randomized clinical trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bandages; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Drainage; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Infections; Length of Stay; Lymph; Methotrexate; Middle Aged; Postoperative Complications; Prospective Studies; Treatment Outcome; Wound Healing | 1997 |
A randomized pilot study of high-dose epirubicin as neoadjuvant chemotherapy in the treatment of cancer of the bilharzial bladder.
Topics: Adult; Carcinoma; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Combined Modality Therapy; Epirubicin; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Postoperative Complications; Schistosomiasis; Survival Rate; Urinary Bladder Neoplasms | 1991 |
11 other study(ies) available for epirubicin and Complication, Postoperative
Article | Year |
---|---|
Outcomes and survival following neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus: Inverse propensity score weighted analysis.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; Disease-Free Survival; Docetaxel; Epirubicin; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Esophagogastric Junction; Female; Fluorouracil; Hospital Mortality; Humans; Length of Stay; Leucovorin; Lymph Node Excision; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Oxaliplatin; Postoperative Complications; Propensity Score; Survival Rate; Treatment Outcome | 2020 |
Union is strength: Textbook outcome with perioperative chemotherapy compliance decreases the risk of death in advanced gastric cancer patients.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Docetaxel; Epirubicin; Female; Fluorouracil; Gastrectomy; Guideline Adherence; Humans; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Outcome and Process Assessment, Health Care; Oxaliplatin; Perioperative Care; Postoperative Complications; Practice Guidelines as Topic; Stomach Neoplasms; Survival Rate | 2022 |
Surgical morbidity and mortality after neoadjuvant chemotherapy in the CRITICS gastric cancer trial.
Topics: Adult; Aged; Aged, 80 and over; Anastomotic Leak; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Epirubicin; Esophagectomy; Female; Gastrectomy; Humans; Induction Chemotherapy; Logistic Models; Lymph Node Excision; Male; Middle Aged; Mortality; Multivariate Analysis; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin; Postoperative Complications; Randomized Controlled Trials as Topic; Risk Factors; Sex Factors; Splenectomy; Stomach Neoplasms | 2018 |
[Postoperative cholangitis of balloon-occluded transarterial chemoembolization (B-TACE) for hepatocellular carcinoma].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Balloon Occlusion; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cholangitis; Cisplatin; Epirubicin; Ethiodized Oil; Female; Humans; Liver Neoplasms; Male; Middle Aged; Postoperative Complications | 2014 |
Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric Adenocarcinoma.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Epirubicin; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Female; Fluorouracil; Follow-Up Studies; Gastrectomy; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Postoperative Complications; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Rate; Taxoids | 2015 |
The impact of neoadjuvant chemotherapy on cardiopulmonary physical fitness in gastro-oesophageal adenocarcinoma.
Topics: Adenocarcinoma; Aged; Anaerobic Threshold; Antineoplastic Combined Chemotherapy Protocols; Cardiorespiratory Fitness; Cisplatin; Epirubicin; Esophageal Neoplasms; Exercise Test; Fluorouracil; Humans; Neoadjuvant Therapy; Oxygen Consumption; Postoperative Complications; Retrospective Studies; Stomach Neoplasms | 2016 |
Veno-occlusive disease as a complication of preoperative chemotherapy for Wilms tumor: A clinico-pathological analysis.
Topics: Alanine Transaminase; Antineoplastic Combined Chemotherapy Protocols; Aspartate Aminotransferases; Chemotherapy, Adjuvant; Child; Child, Preschool; Dactinomycin; Doxorubicin; Epirubicin; Female; Hepatic Veno-Occlusive Disease; Humans; Incidence; Infant; Kidney Neoplasms; Liver; Male; Neoadjuvant Therapy; Nephrectomy; Postoperative Complications; Retrospective Studies; Ultrasonography; Wilms Tumor | 2009 |
Combined modality treatment for patients with locally advanced pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Catheter Ablation; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Deoxycytidine; Epirubicin; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Pancreatic Neoplasms; Postoperative Complications; Treatment Outcome | 2012 |
A rare life-threatening complication of migrated nitinol self-expanding metallic stent (Ultraflex).
Topics: Adenocarcinoma; Aged; Alloys; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deglutition Disorders; Device Removal; Epirubicin; Equipment Design; Esophageal Neoplasms; Fluorouracil; Foreign-Body Migration; Humans; Ileal Diseases; Intestinal Obstruction; Laparotomy; Liver Neoplasms; Male; Postoperative Complications; Stents | 2004 |
Long term results of surgery and chemotherapy in small cell lung cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Cranial Irradiation; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Longitudinal Studies; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonectomy; Postoperative Complications; Prospective Studies; Radiotherapy, Adjuvant; Survival Rate; Vincristine | 1998 |
Current trends in the surgical treatment of esophageal and cardia adenocarcinoma.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Barrett Esophagus; Cardia; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Diagnostic Imaging; Epirubicin; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Fluorouracil; Gastroesophageal Reflux; Humans; Italy; Leucovorin; Life Tables; Lymph Node Excision; Lymphatic Metastasis; Mediastinum; Neoadjuvant Therapy; Neoplasm Staging; Palliative Care; Postoperative Complications; Retrospective Studies; Stomach Neoplasms; Survival Analysis | 1999 |